logo

For the Inventor, By the Inventor

Morristown, NJ, United States of America

Stephen Deems Gabriel

This inventor holds 10 USPTO granted patents and 4 published patent applications and 7 EPO patents. Top assignees: Hoffmann-La Roche Inc., Roche Palo Alto LLC. Active years: 2008-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Deems Gabriel. Retrieved from https://idiyas.com/inventor/stephen-deems-gabriel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 10.0

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • San Mateo, CA (US) (2008 - 2009)
  • Morristown, NJ (US) (2012 - 2017)
  • Winterville, NC (US) (2018)

Company Filing History:

goldMedal7 out of 5,027 
 
Hoffmann-La Roche Inc.
 patents
silverMedal3 out of 322 
 
Roche Palo Alto LLC
 patents

Years Active: 2008-2018

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 9896433 - Antiviral compounds (2018-02-20),
2. 9693997 - Antiviral compounds (2017-07-04),
3. 9540345 - Antiviral compounds (2017-01-10),
4. 9321738 - N-alkyltriazole compounds as LPAR antagonists (2016-04-26),
5. 8940741 - Inhibitors of bruton's tyrosine kinase (2015-01-27),
6. 8697696 - Triazole compounds II (2014-04-15),
7. 8481540 - Inhibitors of bruton's tyrosine kinase (2013-07-09),
8. 8222246 - Substituted isoxazoles (2012-07-17),
9. 7538122 - Heterocyclic antiviral compounds (2009-05-26),
10. 7332500 - Heterocyclic antiviral compounds (2008-02-19),

Title: The Innovative Contributions of Stephen Deems Gabriel

Introduction

Stephen Deems Gabriel is a notable inventor based in Morristown, NJ (US). He has made significant contributions to the field of antiviral compounds, holding a total of 10 patents. His work focuses on developing pharmaceutical compositions that aid in the prevention and treatment of HCV infection.

Latest Patents

Among his latest patents, Gabriel has disclosed compounds of Formula I, wherein the variables in Formula I are defined as described in his inventions. These compounds are crucial in the formulation of pharmaceutical compositions aimed at combating HCV infection. His innovative approach to antiviral compounds showcases his commitment to advancing medical science.

Career Highlights

Throughout his career, Stephen Deems Gabriel has worked with prominent companies such as Hoffmann-La Roche Inc. and Roche Palo Alto LLC. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Gabriel has collaborated with several professionals in his field, including Buelent Kocer and Steven Joseph Berthel. These partnerships have contributed to the success of his projects and the advancement of antiviral research.

Conclusion

Stephen Deems Gabriel's work in antiviral compounds and his extensive patent portfolio highlight his significant impact on the pharmaceutical industry. His dedication to innovation continues to pave the way for advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…